Dr. Christopher Barbieri - Genomic Testing For Prostate Cancer Patients
To request an appointment with Dr. Barbieri in NYC, please call (212) 746-5562.
Dr. Barbieri discusses Genomic Testing For Prostate Cancer Patients, and how this may impact risk stratification and decision to pursue treatment(s).
To learn more about Dr. Barbieri, please visit our website at: https://urology.weillcornell.org/christopher-e-barbieri
Dr. Christopher Barbieri - Genetic Testing For Prostate Cancer Risk Assessment
To request an appointment with Dr. Barbieri in NYC, please call (212) 746-5562.
Dr. Christopher Barbieri discusses recent advances in genetic testing that allow patients to have blood or saliva sampled to help evaluate their risk of developing prostate cancer.
To learn more about prostate cancer, please visit our website at: https://urology.weillcornell.org/prostate-cancer
Research on SPOP Prostate Cancer Subtype Prognosis and PSA levels
Dr. Christopher Barbieri was interviewed as a co-senior author on new prostate cancer research from Weill Cornell Medicine & colleagues, regarding the interpretation of PSA levels in patients with the SPOP prostate cancer subtype.
"These findings are counterintuitive," said co-senior author Dr. Christopher Barbieri, an assistant professor of urology at Weill Cornell Medicine. "In general, if your PSA is higher, the cancer is more dangerous. However, this study found that tumors associated with a high PSA and SPOP mutations were less dangerous."
Dr. Barbieri - Interview with an Expert: Active Surveillance
Christopher Barbieri, M.D., Ph.D., Assistant Professor in Urology and in Cell & Developmental Biology at Weill Cornell Medicine, was interviewed by the Prostate Cancer Foundation on active surveillance for prostate cancer patients. He addresses many of the common questions that patients and providers ask regarding eligibility for active surveillance and treatment protocol.
Dr. Barbieri - Individualized Treatments for Prostate Cancer at Weill Cornell Medicine
To make an appointment with NYC urologist and prostate cancer specialist Dr. Christopher Barbieri, please call our office at (212) 746-5562.
For other inquires and additional providers specializing in prostate cancer care at Weill Cornell Medicine in New York City, please call our office at (646) 962-9600.
Dr. Christopher Barbieri - Physician Profile
To make an appointment with Dr. Christopher Barbieri at Weill Cornell Medicine Urology in New York City, please call our office at (212) 746-5562.
In this video, Christopher Barbieri, M.D., Ph.D. speaks about his experience & expertise in prostate cancer clinical care as a urologist, as well as his research into prostate cancer genomics.
Research Reveals Gene Mutation as Driver of Prostate Cancer Subtype
A newly discovered genetic mutation that is found in a subtype of prostate cancer is integral to the disease’s development and growth, according to research from Weill Cornell Medicine scientists. Their findings could pave the way for new targeted treatment approaches.
Dr. Christopher Barbieri - Defining & Targeting Distinct Molecular Classes of Prostate Cancer
Dr. Christopher Barbieri speaks at an US TOO prostate cancer educational seminar at Weill Cornell Medicine to discuss the role of genomics in the identification and treatment of specific subtypes of prostate cancer, precision medicine tactics, as well as emerging therapies.
We Are Weill Cornell Medicine: Dr. Christopher Barbieri
Dr. Christopher Barbieri was the type of kid who would press every button in the house, much to his parents’ chagrin. Ultimately he learned to put that inquisitiveness to good use as a doctor and scientist, and discovered a new form of prostate cancer.